Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis

Pil-Gu Park; Su Ji Jo; Min Jung Kim; Hyun Jeong Kim; Ji Hae Lee; Cheol Keun Park; Hyunki Kim; Kang Young Lee; Hoguen Kim; Jeon Han Park; Seung Myung Dong; Jae Myun Lee

doi:10.18632/oncotarget.18170

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis

Pil-Gu Park, Su Ji Jo, Min Jung Kim, Hyun Jeong Kim, Ji Hae Lee, Cheol Keun Park, Hyunki Kim, Kang Young Lee, Hoguen Kim, Jeon Han Park, Seung Myung Dong and Jae Myun Lee _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:80325-80335. https://doi.org/10.18632/oncotarget.18170

Metrics: PDF 2382 views | HTML 3025 views | ?

Abstract

Pil-Gu Park1,*, Su Ji Jo1,2,*, Min Jung Kim1,3, Hyun Jeong Kim4, Ji Hae Lee5, Cheol Keun Park6, Hyunki Kim6, Kang Young Lee7, Hoguen Kim2,6, Jeon Han Park1, Seung Myung Dong5,8 and Jae Myun Lee1,2

1Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, Republic of Korea

2BK21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea

3Department of Pediatrics, Severance Hospital, Institute of Allergy, Yonsei University College of Medicine, Seoul, Republic of Korea

4Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

5Research Institute, National Cancer Center, Goyang, Republic of Korea

6Department of Pathology, Yonsei University, College of Medicine, Seoul, South Korea

7Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

8IMK Bio-Convergence R&D Center, International Vaccine Institute SNU Research Park, Seoul, Republic of Korea

*These authors contributed equally to this work

Correspondence to:

Jae Myun Lee, email: [email protected]

Seung Myung Dong, email: [email protected]

Keywords: colorectal cancer, metastasis, LOXL2, epithelial-mesenchymal transition, tissue microarray analysis

Received: March 24, 2017 Accepted: May 11, 2017 Published: May 25, 2017

ABSTRACT

Colorectal cancer (CRC) is one of the most dangerous types of malignant tumors, and cancer metastasis is a major factor in the failure of CRC therapy. Recently, LOXL2 (lysyl oxidase-like 2) has been shown to represent a regulator of epithelial-mesenchymal transition (EMT) in different cancer types. However, LOXL2 has not been reported to be involved in CRC metastasis. In this study, we demonstrated that LOXL2 expression is strongly correlated with the rate of CRC metastasis, it participates in the regulation of EMT-related molecule expression in CRC cells in vitro, and it is involved in migratory potential alterations. Additionally, tissue microarray analysis of CRC patients showed an increase in the probability of developing CRC distant metastasis and a decrease in the survival rate of patients with high LOXL2 expression. The results obtained in this study indicate that LOXL2 is involved in the development and progression of CRC metastasis, and therefore, its expression levels may represent a useful prognostic marker.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18170

Publication Alerts

Research Papers:

Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis

Abstract